Literature DB >> 3968508

Autoradiographic studies of androgen-binding sites in the rat urogenital sinus and postnatal prostate.

H Takeda, T Mizuno, I Lasnitzki.   

Abstract

Binding sites of [3H]testosterone and [3H]dihydrotestosterone in the rat fetal urogenital sinus and postnatal prostate and vagina grown in vitro were examined by steroid autoradiography. Distinct nuclear incorporation of both androgens appeared between 14.5 and 16.5 days of gestation in rat fetuses. Nuclear labelling in the sinus was restricted to the mesenchyme surrounding the epithelium which showed no nuclear labelling. A similar distribution of labelled cells was observed in male and female sinuses up to 18.5 days of gestation. By 20.5 days of gestation, the labelling in the ventral mesenchyme of female urogenital sinuses became less intense but persisted in the mesenchyme of the dorsal sinus wall from which the vagina is formed. In the postnatal prostate, the epithelium showed nuclear [3H]testosterone labelling at 10 days coinciding with the onset of its functional differentiation. Epithelial labelling became more intensive at 4 weeks post partum while that of the mesenchyme declined. The results suggest two phases of androgen action: formation of the prostatic buds mediated by the androgen-activated mesenchyme of the fetal urogenital sinus and the differentiation of the postnatal prostatic epithelium directly stimulated by androgens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968508     DOI: 10.1677/joe.0.1040087

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  16 in total

1.  Distribution and regulation of progesterone receptor in the urogenital tract of the chick embryo. An immunohistochemical study.

Authors:  J M Gasc
Journal:  Anat Embryol (Berl)       Date:  1991

Review 2.  Molecular signaling pathways that regulate prostate gland development.

Authors:  Gail S Prins; Oliver Putz
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

3.  Autoradiographic studies of the localisation of androgen-binding cells in the genital tubercles of fetal rats.

Authors:  R Murakami
Journal:  J Anat       Date:  1987-04       Impact factor: 2.610

4.  Embryonic cholinesterase activity during morphogenesis of the mouse genital tract. Light- and electron-microscopic observations.

Authors:  K U Thiedemann; P Vanittanakom; F M Schweers; U Drews
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

Review 5.  Therapeutic targeting of the prostate cancer microenvironment.

Authors:  Maria Karlou; Vassiliki Tzelepi; Eleni Efstathiou
Journal:  Nat Rev Urol       Date:  2010-09       Impact factor: 14.432

6.  LEF1 identifies androgen-independent epithelium in the developing prostate.

Authors:  Xinyu Wu; Garrett Daniels; Ellen Shapiro; Kun Xu; Hongying Huang; Yirong Li; Susan Logan; M Alba Greco; Yi Peng; Marie E Monaco; Jonathan Melamed; Herbert Lepor; Irina Grishina; Peng Lee
Journal:  Mol Endocrinol       Date:  2011-04-28

Review 7.  Exploring the origins of the normal prostate and prostate cancer stem cell.

Authors:  Susan Kasper
Journal:  Stem Cell Rev       Date:  2008-09       Impact factor: 5.739

Review 8.  Stromal androgen receptor in prostate development and cancer.

Authors:  Mandeep Singh; Ruchi Jha; Jonathan Melamed; Ellen Shapiro; Simon W Hayward; Peng Lee
Journal:  Am J Pathol       Date:  2014-08-01       Impact factor: 4.307

9.  Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.

Authors:  Chun-Te Wu; Saleh Altuwaijri; William A Ricke; Shu-Pin Huang; Shuyuan Yeh; Caixia Zhang; Yuanjie Niu; Meng-Ying Tsai; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-25       Impact factor: 11.205

10.  Intersex mice composed of androgen insensitive Tfm and wild-type cells analysed by 3H dihydrotestosterone autoradiography.

Authors:  G Schleicher; W E Stumpf; K U Thiedemann; U Drews
Journal:  Anat Embryol (Berl)       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.